• December 10, 2009
  Azaya Therapeutics Receives FDA Authorization to Start Phase I Cancer Trial
  More 
   
• Cell Therapy is Alive and Well
  By Cori Gorman, Ph.D., MBA, DNA Bridges, Inc.
  Featured in Bio Show Daily, Tuesday, May 19, 2009. Page 22
  More 
   
• Personalized Medicine Can Increase Revenues
  By Cammie Edwards, Ph.D., DNA Bridges, Inc.
  Featured in Bio Show Daily, Tuesday, May 19, 2009. Page 33.
  More 
   
• October 5, 2009
  Depomed, Inc. Announces Positive Top-Line Results from Phase 3 Clinical Trial of DM-1796 in Postherpetic Neuralgia
  Menlo Park, Calif
  More 
   
• August 10, 2009
  Depomed Reports Encouraging Results of its Phase I Trial for DM-1992 Program in Parkinson's Disease
  Menlo Park, Calif
  More 
   
• September 22, 2009
  Selexis and Neogenix Oncology enter into research services agreement
  Geneva, Switzerland, and Great Neck, New York
  More 
   
• September 18, 2009
  Wyeth and Ambrx Form Multi-target Alliance to Leverage Recent Ambrx Biologics Platform Advances
  Collegeville, PA and San Diego, CA
  More 
   
• September 17, 2009
  to-BBB technology will be used by MedImmune to evaluate brain drug delivery mechanism
  Leiden, The Netherlands
  More 
   
• August 31, 2009
  Selexis and NKT Therapeutics enter into research services agreement
  Geneva, Switzerland
  More 
   
• August 6, 2009
  to-BBB climbs up the international CNS drug delivery ranking
  Leiden, The Netherlands
  More 
   

more news...